MRC Clinical Trials Unit at UCL
Menu
Home
About
Our Structure
Our People
History
'25 at 25' series
Our Environmental Commitment
News
Research
Cancer
Add-Aspirin
ARCHERY
RAMPART
REFINE
STAMPEDE
STAMPEDE2
STOPCAP M1
UKCTOCS
PATCH
Open studies
Past Studies
Infections
Studies by Research Area
Neurodegenerative Diseases
ACORD collaboration
MRC Clinical Trials Unit ACORD Fellows Academy
OCTOPUS
EJS ACT-PD
Methodology
Design
Conduct
Analysis
Meta-analysis
Software
Other Research & Policy
Data Sharing
Publications
Studies in other areas
Briefing Papers
Regulatory information, Toolkits & Templates
Our podcast
Studies
All Studies
Studies Search
Patients & Public
About Clinical Trials
What is a clinical trial?
What is a randomised clinical trial?
What is an observational study?
How do we make sure a trial is safe?
How is a trial designed and run?
What happens at the end of a trial?
Taking Part in a Clinical Trial
How can you take part in a trial?
What questions should you ask before participating in a trial?
Patient and Public Involvement
About our PPI group
Our PPI Strategy
PPI Resources
Study & Careers
Capacity Strengthening
Enhancing skills of trial teams we work with across the globe
Improving the clinical trials ecosystem
NIHR Associate Principal Investigator (PI) Scheme
Contact
Search the site
Sitemap
Home
About Us
Our Structure
History
'25 at 25' series
Our Environmental Commitment
News
Our Research
Cancer
Add-Aspirin
ARCHERY
RAMPART
REFINE
STAMPEDE
STAMPEDE2
STOPCAP M1
UKCTOCS
PATCH
Open studies
Past Studies
Infections
Studies by Research Area
HIV
Hepatitis C
Tuberculosis
Influenza & other respiratory diseases
Bacterial Infection
Pneumonia
The Acutely Sick Child
Other Research Areas
COVID-19
Neurodegenerative Diseases
ACORD collaboration
MRC Clinical Trials Unit ACORD Fellows Academy
OCTOPUS
EJS ACT-PD
Methodology
Design
Multi-Arm Multi-Stage (MAMS) platform trials
Workshop Tutorial for MAMS trials
MAMS Clinic
MAMS Workshop Videos nstage examples
MRC CTU Symposium - Innovative phase III randomised clinical trial designs
ROCI design
PRACTical design
Factorial trials
Sharing our expertise in MAMS platform designs
Advanced sample size software
Efficient cluster-randomised trials
Efficient non-inferiority trials
Conduct
KMunicate
Practical implementation of new trial designs
Healthcare systems data
Clinical trials monitoring toolkit
Direct and indirect comparisons
Academic trials as regulatory submissions
Improving communication of results
Analysis
Covariate adjustment in trials
Estimands
Missing data
Estimation and causal inference
Simulation studies
Sensitivity analysis
Meta-analysis
Software
Other Research & Policy
Data Sharing
Studies in other areas
Briefing Papers
Regulatory information, Toolkits & Templates
Our podcast
Patients & Public
About Clinical Trials
What is a clinical trial?
What is a randomised clinical trial?
What is an observational study?
How do we make sure a trial is safe?
How is a trial designed and run?
What happens at the end of a trial?
Taking Part in a Clinical Trial
How can you take part in a trial?
What questions should you ask before participating in a trial?
Patient and Public Involvement
About our PPI group
Our PPI Strategy
PPI Resources
Capacity Building
Enhancing skills of trial teams we work with across the globe
Improving the clinical trials ecosystem
NIHR Associate Principal Investigator (PI) Scheme
Careers
Contact
Posters
f263a47a-e49a-49fc-8100-138887d0eb86
Use of participate in OCTOPUS
Exploring different objectives in non-inferiority trials
Current practice around the use of estimands in cluster randomised trials, and the impacts of informative cluster size on inferences
Driving innovation in late phase trials for neuro-degenerative diseases trials:- cross-disease collaboration essential
Involving trialists in evidence synthesis: benefits for trials and meta-analyses
Specifying estimands and estimators in trials with complex designs
Innovative Approaches to Long-Term Follow-Up: Lessons from an Adjuvant Oncology Trial
Getting our ducks in a row: the need for data utility comparisons of healthcare systems data for clinical trials
Data sharing experiences from the publicly accessible WHO TB IPD platform (TB-IPD)
Setting the standard: Implementing change in standardising data collection by using CDISC
Aligning estimators with estimands for data truncation by death in randomised clinical trials: a case study
Exploring methods for borrowing evidence across baskets or subgroups in a clinical trial: a simulation study
Data utility comparison studies (DUCkS) of adjuvant chemotherapy & radiotherapy treatments in the STAMPEDE trial
KTE
Beginning to identify the burdens of safety reporting for trials unit staff: an exploratory qualitative study
CrossWord: Consent to access and use healthcare systems data for clinical trials – a review of current language in participant-facing materials
Approaches to facilitate clinical trial conduct in hospitalised children and neonates in resource-constrained settings
Identifying a comprehensive “long list” of outcomes for developing a core outcome set for severe malaria treatment trials: A systematic review and inclusion of outcomes important to patients and caregivers.
Creating a Trial Monitoring Plan (TMP) template with knowledgeable input using a Delphi survey
Learning from Agile programming methodology: using 'retrospectives' to improve database development in clinical trials
Measuring Success in Clinical Transformation Initiatives: Using the BCG DICE ℗ Score to Reflect on RBQM Implementation
Navigating through the re-design of a multi-arm, multi-stage (MAMS) trial in light of external data; introducing tools to make the most of the available randomised evidence
What estimands can be used when interventions may be given more than once?
Strategies for maintaining double-blinding when including treatments with different modalities in multi-arm multi-stage trials: what works?
SPECTRE Site Setup Process Mapping
Books
Handbook of Meta-Analysis
Data and Code
Errata
Glossary
Privacy
Cookies
Accessibility
Home
Sitemap